EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028

Lifesciences | Pharmaceuticals

EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028

Market by Product, Application, End-user, and Country | Forecast 2021-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

As per Triton’s research report, the pharmaceutical continuous manufacturing market in Europe is anticipated to advance at a CAGR of 10.08% in revenue during the reviewed years 2021-2028. 


Report scope can be customized per your requirements. Request For Customization

The countries studied in this market include:

•        The UK

•        Spain

•        Germany

•        Italy

•        France

•        Russia

•        Rest of Europe

In Europe, the studied market is likely to experience substantial growth over the considered years. This progress is motivated by the surge in demand for technologically advanced systems, an increase in the preference for continuous manufacturing, and the availability of continuous manufacturing systems. Additionally, the presence of prominent players adds to the growth of the pharmaceutical continuous manufacturing market across the region.

Germany, for instance, is among the top locations for research, production, and distribution of pharmaceuticals. Moreover, exceptional research units, the presence of renowned scientists, and the well-developed pharmaceutical industry, have transformed Germany into a unique business location. Additionally, the growing population has created several challenges, resulting in the high demand for pharmaceutical products. Above all, there is a steady shift from batch to continuous manufacturing over the years, which is likely to boost Germany’s pharmaceutical continuous manufacturing market’s progression in the next few years.

On the other hand, France is one of the largest consumers of pharmaceutical products. Moreover, the country’s pharmaceutical sector garners significant revenue, ranking fourth globally in prescription medicines. Additionally, the massive production of active pharmaceutical ingredients is likely to help develop continuous manufacturing in pharmaceuticals, in turn, boosting the pharmaceutical continuous manufacturing market on a growth path.

GEA Group AG is involved in offering process technology and components for several industries, including food, pharmaceutical, transportation, and personal care industries. Its product portfolio entails chillers and heat pumps, automation systems, brewing systems, ice machines, separation equipment, cleaners & sterilizers, and others. Moreover, the company has advanced its technologies and methods over the years, owing to its vigorous R&D activities. It has headquarters located in Germany, with business operations spread across multiple regions.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. PORTER’S FIVE FORCES MODEL

2.1.1.   THREAT OF NEW ENTRANTS

2.1.2.   THREAT OF SUBSTITUTE PRODUCTS

2.1.3.   BARGAINING POWER OF BUYERS

2.1.4.   BARGAINING POWER OF SUPPLIERS

2.1.5.   COMPETITIVE RIVALRY

2.2. IMPACT OF COVID-19 ON PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET

2.3. LEGAL, POLICY, & REGULATORY FRAMEWORK

2.4. MARKET ATTRACTIVENESS INDEX

2.5. VENDOR SCORECARD

2.6. KEY INSIGHTS

2.7. MARKET DRIVERS

2.7.1.   RISE IN INITIATIVES BY REGULATORY AUTHORITIES FOR THE ADOPTION OF CONTINUOUS MANUFACTURING

2.7.2.   SURGING ACCEPTANCE OF PHARMACEUTICAL CONTINUOUS MANUFACTURING SYSTEMS

2.7.3.   RISING HEALTHCARE EXPENDITURE

2.8. MARKET RESTRAINTS

2.8.1.   RISING CUSTOMER EXPECTATIONS FOR BETTER MEDICINES

2.9. MARKET OPPORTUNITIES

2.9.1.   SURGE IN THE MANUFACTURING OF LARGE MOLECULES AND BIOLOGICS

3.    EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET OUTLOOK - BY PRODUCT

3.1. INTEGRATED CONTINUOUS SYSTEM

3.2. SEMI-CONTINUOUS SYSTEM

3.3. CONTROL & SOFTWARE

4.    EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET OUTLOOK - BY APPLICATION

4.1. FINAL DRUG PRODUCT MANUFACTURING

4.2. API MANUFACTURING

5.    EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET OUTLOOK - BY END-USER

5.1. PHARMACEUTICAL COMPANIES

5.2. CONTRACT MANUFACTURING ORGANIZATIONS

5.3. OTHER END-USERS

6.    PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET - EUROPE

6.1. COUNTRY ANALYSIS

6.1.1. GERMANY

6.1.2. FRANCE

6.1.3. UNITED KINGDOM

6.1.4. ITALY

6.1.5. RUSSIA

6.1.6. SPAIN

6.1.7. REST OF EUROPE

7.    COMPANY PROFILE

7.1. HOSOKAWA MICRON CORPORATION

7.2. GEA GROUP AG

7.3. LB BOHLE MASCHINEN + VERFAHREN GMBH

7.4. THERMOFISHER SCIENTIFIC INC

7.5. SIEMENS HEALTHINEERS

7.6. ELI LILLY & COMPANY

7.7. PFIZER INC

7.8. GLATT GMBH

7.9. SYNTEGON (FORMERLY BOSCH PACKAGING TECHNOLOGY)

7.10. GEBRUDER LODIGE MASCHINENBAU GMBH

7.11. KORSCH AG

7.12. COPERION GMBH

7.13. MUNSON MACHINERY COMPANY

8.    RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.1.1.   OBJECTIVES OF STUDY

8.1.2.   SCOPE OF STUDY

8.2. SOURCES OF DATA

8.2.1.   PRIMARY DATA SOURCES

8.2.2.   SECONDARY DATA SOURCES

8.3. RESEARCH METHODOLOGY

8.3.1.   EVALUATION OF PROPOSED MARKET

8.3.2.   IDENTIFICATION OF DATA SOURCES

8.3.3.   ASSESSMENT OF MARKET DETERMINANTS

8.3.4.   DATA COLLECTION

8.3.5.   DATA VALIDATION & ANALYSIS

List of table

TABLE 1:       EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 2:       EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 3:       EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 4:       EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 5:       EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1:     EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 2:     EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY INTEGRATED CONTINUOUS SYSTEM, 2021-2028 (IN $ MILLION)

FIGURE 3:     EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY SEMI-CONTINUOUS SYSTEM, 2021-2028 (IN $ MILLION)

FIGURE 4:     EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY CONTROL & SOFTWARE, 2021-2028 (IN $ MILLION)

FIGURE 5:     EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY FINAL DRUG PRODUCT MANUFACTURING, 2021-2028 (IN $ MILLION)

FIGURE 6:     EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY API MANUFACTURING, 2021-2028 (IN $ MILLION)

FIGURE 7:     EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PHARMACEUTICAL COMPANIES, 2021-2028 (IN $ MILLION)

FIGURE 8:     EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY CONTRACT MANUFACTURING ORGANIZATIONS, 2021-2028 (IN $ MILLION)

FIGURE 9:     EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)

FIGURE 10:  GERMANY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 11:  FRANCE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 12:  UNITED KINGDOM PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 13:  ITALY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 14:  RUSSIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 15:  SPAIN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 16:  REST OF EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;